rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    TMCI
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Stifel upgrades Treace Medical stock on growth, profitability outlook
      Nov 9Investing.comTMCI
      Treace Medical Concepts Inc (TMCI) Q3 2026 Earnings Call Highlights: Revenue Slips 4% but ...
      Nov 6Yahoo FinanceTMCI
      What Treace Medical Concepts (TMCI) Said on Its Q3 Earnings Call
      Nov 6Yahoo FinanceTMCI
      Treace Medical Concepts, Inc. Q3 2026 Earnings Call Summary
      Nov 6Yahoo FinanceTMCI
      Treace Medical Concepts Q3 2026 Earnings Call Transcript
      Nov 6BenzingaTMCI
      Treace Medical Concepts earnings beat by $0.06, revenue topped estimates
      Nov 6Investing.comTMCI
      Treace Medical completes first surgeries with bunionette system
      Nov 6Investing.comTMCI
      Treace Medical Concepts (TMCI) Reports Q3 Loss, Tops Revenue Estimates

      Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of +26.92% and +1.18%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

      Nov 6Yahoo FinanceTMCI
      Treace Medical Concepts: Q3 Earnings Snapshot
      Nov 6Yahoo FinanceTMCI
      Treace Medical Concepts Reports Third Quarter 2026 Financial Results
      Nov 6Yahoo FinanceTMCI
      Treace to Report Third Quarter 2026 Financial Results on November 6, 2026
      Oct 23Yahoo FinanceTMCI
      Did Treace Medical Concepts, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
      Sep 25MorningstarTMCI
      Treace Medical (TMCI) Reports Five-Year Bunion Results. Can Evidence Drive Adoption?

      Treace Medical Concepts, Inc. (NASDAQ:TMCI) announced five-year ALIGN3D results on September 17, adding longer-term evidence for the Lapiplasty bunion-correction procedure. The final analysis included 137 of 173 treated patients, or approximately 79% of the original group. Reported radiographic recurrence was 0.8% when defined as a hallux valgus angle greater than 20 degrees and 5.3% using […]

      Sep 23Yahoo FinanceTMCI
      Treace Medical Looks Unlikely To Recover, A Founder-Led Broken Growth Story (NASDAQ:TMCI)

      Treace Medical outlook: revenue declines, Lapiplasty losing share, margins compressing, and EBITDA delayed. Click for more on TMCI stock.

      Sep 20Seeking AlphaTMCI
      Treace Medical presents 5-year bunion surgery study results
      Sep 17Investing.comTMCI
      Treace Highlights Product Innovations and Clinical Data Across its Expanding Foot & Ankle Portfolio at the 2026 AOFAS Annual Meeting
      Sep 15Yahoo FinanceTMCI

      This is the newest page. Registered accounts read further back.